Search Results - "Pandya, Amit"
-
1
Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
Published in The New England journal of medicine (20-10-2022)“…In two phase 3, double-blind, placebo-controlled trials, the Janus kinase inhibitor ruxolitinib showed superiority to vehicle control in facial repigmentation…”
Get full text
Journal Article -
2
New discoveries in the pathogenesis and classification of vitiligo
Published in Journal of the American Academy of Dermatology (01-07-2017)“…Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. This…”
Get full text
Journal Article -
3
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort
Published in Journal of the European Academy of Dermatology and Venereology (01-11-2023)“…Objectives To prospectively examine the association between the duration of unemployment among job seekers and changes in alcohol use in a year. Design A…”
Get full text
Journal Article -
4
Melasma Treatment: An Evidence-Based Review
Published in American journal of clinical dermatology (01-04-2020)“…Background Melasma is an acquired, chronic pigmentary disorder predominantly affecting women. It may significantly affect quality of life and self-esteem due…”
Get full text
Journal Article -
5
Oral Tranexamic Acid for the Treatment of Melasma: A Review
Published in Dermatologic surgery (01-06-2018)“…BACKGROUNDMelasma is a common acquired disorder of hyperpigmentation that commonly affects those with skin of color. Tranexamic acid (TXA) is a novel treatment…”
Get full text
Journal Article -
6
A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
Published in Journal of the American Academy of Dermatology (01-08-2019)Get full text
Journal Article -
7
Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial
Published in The Lancet (British edition) (11-07-2020)“…Vitiligo is a chronic autoimmune disease resulting in skin depigmentation and reduced quality of life. There is no approved treatment for vitiligo…”
Get full text
Journal Article -
8
Current and emerging treatments for vitiligo
Published in Journal of the American Academy of Dermatology (01-07-2017)“…Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is…”
Get full text
Journal Article -
9
Melasma: A comprehensive update Part I
Published in Journal of the American Academy of Dermatology (01-10-2011)“…Melasma is a common disorder of hyperpigmentation affecting millions of people worldwide. While it is thought to be triggered or exacerbated by sun exposure…”
Get full text
Journal Article -
10
Noticeability of vitiligo is in the eye of the beholder
Published in British journal of dermatology (1951) (01-10-2022)“…Linked Article: Batchelor et al. Br J Dermatol 2022; 187:548–556…”
Get full text
Journal Article -
11
Psychosocial Effects of Vitiligo: A Systematic Literature Review
Published in American journal of clinical dermatology (01-11-2021)“…Background Patients with vitiligo experience reduced quality of life. Objective To comprehensively describe the available evidence for psychosocial burden in…”
Get full text
Journal Article -
12
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
Published in Journal of the American Academy of Dermatology (01-02-2023)“…Vitiligo is a chronic autoimmune disorder characterized by depigmented patches of the skin. To evaluate the efficacy and safety of ritlecitinib, an oral JAK3…”
Get full text
Journal Article -
13
Melasma: clinical diagnosis and management options
Published in Australasian journal of dermatology (01-08-2015)“…Melasma is a common acquired disorder of pigmentation most commonly seen in those with skin of colour. It has long been a condition that is frustrating for…”
Get full text
Journal Article -
14
Increasing racial and ethnic diversity in dermatology: A call to action
Published in Journal of the American Academy of Dermatology (01-03-2016)Get full text
Journal Article -
15
Melasma: A comprehensive update Part II
Published in Journal of the American Academy of Dermatology (01-10-2011)“…Several methods of treatment are available to patients with melasma. First-line therapy usually consists of topical compounds that affect the pigment…”
Get full text
Journal Article -
16
Cultural Competence and Humility
Published in Dermatologic clinics (01-04-2023)“…The increasing diversification of the United States has led to more racially and ethnically discordant visits between health care providers and patients; this…”
Get full text
Journal Article -
17
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo
Published in Science translational medicine (18-07-2018)“…Vitiligo is an autoimmune disease of the skin mediated by CD8 T cells that kill melanocytes and create white spots. Skin lesions in vitiligo frequently return…”
Get more information
Journal Article -
18
Treatment of Melasma with Topical Agents, Peels and Lasers: An Evidence-Based Review
Published in American journal of clinical dermatology (01-10-2013)“…Background Melasma is an acquired disorder of hyperpigmentation occurring on the face and predominantly affecting women of childbearing age. It is a chronic,…”
Get full text
Journal Article -
19
Prevalence of Vitiligo Among Adults in the United States
Published in JAMA dermatology (Chicago, Ill.) (01-01-2022)“…Vitiligo can have profound effects on patients and is often associated with other autoimmune comorbid conditions. It is important to understand the current…”
Get more information
Journal Article -
20
Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine
Published in Arteriosclerosis, thrombosis, and vascular biology (01-11-2015)“…OBJECTIVE—Prevalence of vitamin D (VD) deficiency and its association with the risk of cardiovascular disease prompted us to evaluate the effect of VD status…”
Get full text
Journal Article